Literature DB >> 28359606

Diagnosis and Treatment of Drug-Resistant Tuberculosis.

José A Caminero1, Joan A Cayla2, José-María García-García3, Francisco J García-Pérez4, Juan J Palacios5, Juan Ruiz-Manzano6.   

Abstract

In the last 2 decades, drug-resistant tuberculosis has become a threat and a challenge to worldwide public health. The diagnosis and treatment of these forms of tuberculosis are much more complex and prognosis clearly worsens as the resistance pattern intensifies. Nevertheless, it is important to remember that with the appropriatesystematic clinical management, most of these patients can be cured. These guidelines itemize the basis for the diagnosis and treatment of all tuberculosis patients, from those infected by strains that are sensitive to all drugs, to those who are extensively drug-resistant. Specific recommendations are given forall cases. The current and future role of new molecular methods for detecting resistance, shorter multi-drug-resistant tuberculosis regimens, and new drugs with activity against Mycobacterium tuberculosis are also addressed.
Copyright © 2017 SEPAR. Publicado por Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Diagnosis; Diagnóstico; Drug-resistant tuberculosis; Extremely drug-resistant tuberculosis; Multi-drug-resistant tuberculosis; Tratamiento; Treatment; Tuberculosis; Tuberculosis con resistencia a fármacos; Tuberculosis multi-drogorresistente

Mesh:

Substances:

Year:  2017        PMID: 28359606     DOI: 10.1016/j.arbres.2017.02.006

Source DB:  PubMed          Journal:  Arch Bronconeumol        ISSN: 0300-2896            Impact factor:   4.872


  4 in total

Review 1.  Adapting Clofazimine for Treatment of Cutaneous Tuberculosis by Using Self-Double-Emulsifying Drug Delivery Systems.

Authors:  Daniélle van Staden; Richard K Haynes; Joe M Viljoen
Journal:  Antibiotics (Basel)       Date:  2022-06-15

2.  Differences in the Structure and Antimicrobial Activity of Hydrazones Derived from Methyl 4-Phenylpicolinimidate.

Authors:  Katarzyna Gobis; Małgorzata Szczesio; Andrzej Olczak; Izabela Korona-Głowniak; Ewa Augustynowicz-Kopeć; Ida Mazernt-Politowicz; Dagmara Ziembicka; Marek L Główka
Journal:  Materials (Basel)       Date:  2022-04-24       Impact factor: 3.748

Review 3.  [Control and management strategies in multidrug-resistant tuberculosis: literature reviewEstrategias de control y atención de la tuberculosis multirresistente: una revisión de la literatura].

Authors:  Jaqueline Garcia de Almeida Ballestero; Mônica Cristina Ribeiro Alexandre D Auria de Lima; Juliana Masini Garcia; Roxana Isabel Cardozo Gonzales; Amélia Nunes Sicsú; Fernando Mitano; Pedro Fredemir Palha
Journal:  Rev Panam Salud Publica       Date:  2019-02-06

4.  A Dual Marker for Monitoring MDR-TB Treatment: Host-Derived miRNAs and M. tuberculosis-Derived RNA Sequences in Serum.

Authors:  Claudia Carranza; María Teresa Herrera; Silvia Guzmán-Beltrán; Manuel Guadalupe Salgado-Cantú; Ivan Salido-Guadarrama; Elizabeth Santiago; Leslie Chávez-Galán; Luis Horacio Gutiérrez-González; Yolanda González
Journal:  Front Immunol       Date:  2021-11-04       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.